Solventum (SOLV) has been in focus among investors as the stock showed some movement over the past week, catching attention because of changes in its recent performance and valuation. See our latest ...
ST. PAUL, Minn., Aug. 13, 2025 /PRNewswire/ -- Solventum Corporation (NYSE: SOLV, "Company" or "Solventum") today announced the launch of a secondary offering (the "Offering") of 8,800,000 shares of ...
Solventum, the recently spun off healthcare arm of 3M, faces challenges in value creation due to stagnant growth, heavy debt burden, and entanglement with its former parent. The company's revenue ...
On Thursday, Solventum (NYSE:SOLV) hosted its 2025 Investor Day, during which it outlined its strategic priorities, its business segments, and its long-range plan (LRP) to drive growth and value ...
10monon MSN
Solventum: Q4 EPS Beats, Cash Flow Dips
Diversified healthcare company Solventum (NYSE:SOLV) reported fourth-quarter 2024 earnings on Thursday, Feb. 27, that topped ...
*Data in the schedule above is intentionally rounded to the nearest million and, therefore, may not sum. 2 Constant currency represents the change in net sales absent the impact on sales from foreign ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback